Medicine
Clindamycin 300 mg capsule
Clindamycin 300 mg capsule is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20° to 25° C (68° to 77° F).
Key facts
- Active ingredient (INN)
- Clindamycin
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 16 capsules and 192 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaMicro LabsIndiaGlenmark PharmaceuticalsIndiaA-S Medication SolutionsVerityrxAmneal Pharmaceuticals NYChartwell RX28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20° to 25° C (68° to 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF01 Clindamycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 March 2001
- Identifiers
- RxCUI 284215, 197518, 309329DailyMed set ID f7e51a42-bc9e-490f-b8d8-8765f0b5be46, 427a0138-c2dd-cf0b-e063-6394a90af407, d6e1a5f2-9dcb-49fb-a5b0-d7d543520ac3 +37NDC 71205-444, 83939-0019, 63187-127 +37Application ANDA207402, ANDA065442, ANDA216957 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 195 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 65862-186-01 | Aurobindo PharmaIndia | 26 August 2009 |
| 500 capsule in 1 bottle | 65862-186-05 | Aurobindo PharmaIndia | 26 August 2009 |
| 16 capsule in 1 bottle | 65862-186-16 | Aurobindo PharmaIndia | 26 August 2009 |
| 100 capsule in 1 bottle | 68462-144-01 | Glenmark PharmaceuticalsIndia | 10 March 2023 |
| 3 blister pack in 1 carton / 20 capsule in 1 blister pack | 68462-144-81 | Glenmark PharmaceuticalsIndia | 10 March 2023 |
| 100 capsule in 1 bottle | 42571-252-01 | Micro LabsIndia | 7 January 2019 |
| 500 capsule in 1 bottle | 42571-252-05 | Micro LabsIndia | 7 January 2019 |
| 1000 capsule in 1 bottle | 42571-252-10 | Micro LabsIndia | 7 January 2019 |
| 100 capsule in 1 bottle | 63304-693-01 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 10 capsule in 1 bottle | 63304-693-03 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 500 capsule in 1 bottle | 63304-693-05 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 16 capsule in 1 bottle | 63304-693-16 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 100 capsule in 1 carton | 63304-693-77 | Sun Pharmaceutical IndustriesIndia | 23 March 2001 |
| 3 blister pack in 1 carton / 10 capsule, gelatin coated in 1 blister pack | 69238-2121-3 | Amneal Pharmaceuticals NY | 25 April 2022 |
| 100 capsule in 1 bottle | 62135-766-01 | Chartwell RX | 12 January 2024 |
| 1 capsule in 1 pouch | 83939-0019-1 | Verityrx | 3 November 2025 |
| 50 pouch in 1 box, unit-dose / 1 capsule in 1 pouch | 83939-0019-2 | Verityrx | 3 November 2025 |
| 100 pouch in 1 box, unit-dose / 1 capsule in 1 pouch | 83939-0019-3 | Verityrx | 3 November 2025 |
| 30 capsule in 1 bottle | 50090-0967-0 | A-S Medication Solutions | 28 November 2014 |
| 45 capsule in 1 bottle | 50090-0967-1 | A-S Medication Solutions | 28 November 2014 |
| 16 capsule in 1 bottle | 50090-0967-2 | A-S Medication Solutions | 28 November 2014 |
| 40 capsule in 1 bottle | 50090-0967-3 | A-S Medication Solutions | 28 November 2014 |
| 20 capsule in 1 bottle | 50090-0967-4 | A-S Medication Solutions | 28 November 2014 |
| 30 capsule in 1 bottle | 50090-3907-0 | A-S Medication Solutions | 5 December 2018 |
| 45 capsule in 1 bottle | 50090-3907-1 | A-S Medication Solutions | 5 December 2018 |
| 16 capsule in 1 bottle | 50090-3907-2 | A-S Medication Solutions | 5 December 2018 |
| 40 capsule in 1 bottle | 50090-3907-3 | A-S Medication Solutions | 5 December 2018 |
| 20 capsule in 1 bottle | 50090-3907-4 | A-S Medication Solutions | 5 December 2018 |
| 3 capsule in 1 bottle | 50090-3907-5 | A-S Medication Solutions | 14 May 2024 |
| 30 capsule in 1 bottle | 50090-4575-0 | A-S Medication Solutions | 4 October 2019 |
| 45 capsule in 1 bottle | 50090-4575-1 | A-S Medication Solutions | 4 October 2019 |
| 16 capsule in 1 bottle | 50090-4575-2 | A-S Medication Solutions | 4 October 2019 |
| 40 capsule in 1 bottle | 50090-4575-3 | A-S Medication Solutions | 4 October 2019 |
| 20 capsule in 1 bottle | 50090-4575-4 | A-S Medication Solutions | 4 October 2019 |
| 30 capsule in 1 bottle | 50090-7354-0 | A-S Medication Solutions | 16 October 2024 |
| 45 capsule in 1 bottle | 50090-7354-1 | A-S Medication Solutions | 16 October 2024 |
| 16 capsule in 1 bottle | 50090-7354-2 | A-S Medication Solutions | 16 October 2024 |
| 40 capsule in 1 bottle | 50090-7354-3 | A-S Medication Solutions | 16 October 2024 |
| 20 capsule in 1 bottle | 50090-7354-4 | A-S Medication Solutions | 16 October 2024 |
| 3 capsule in 1 bottle | 50090-7354-5 | A-S Medication Solutions | 16 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 February 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clindamycin 300 mg capsule.
Other strengths and forms of Clindamycin
Clinical summary
Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cleocin Hydrochloride prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Clindamycin 300 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.